Our concept began when we measured a significant correlation between random errors and the reagents used in experiments. Curiosity led us beyond the bench to work on identifying a variety of contributing factors which included such issues as poor manufacturing standards, inconsistent data and supplier handling.
We determined that a large majority of these factors were avoidable, so we began building a repository of solutions to help minimize the risk of error. We provide research laboratories in early-to-late phase discovery with synthetic bioreagents; ssDNA, RNA and Recombinant Proteins specific to their target objectives.
